-+ 0.00%
-+ 0.00%
-+ 0.00%

OUTLOOK THERAPEUTICS® ANNOUNCES SMC RECOMMENDATION OF LYTENAVA™ (BEVACIZUMAB GAMMA) FOR THE TREATMENT OF WET AMD

Reuters·06/10/2025 12:05:00

Please log in to view news